Focus Partners Advisor Solutions LLC lessened its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 56.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,523 shares of the company's stock after selling 4,483 shares during the quarter. Focus Partners Advisor Solutions LLC's holdings in Corteva were worth $201,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of CTVA. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Corteva by 5.5% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,089,845 shares of the company's stock worth $232,958,000 after buying an additional 214,256 shares in the last quarter. Waverly Advisors LLC lifted its holdings in Corteva by 18.6% during the 4th quarter. Waverly Advisors LLC now owns 14,369 shares of the company's stock valued at $818,000 after buying an additional 2,250 shares in the last quarter. Woodline Partners LP purchased a new stake in Corteva in the 4th quarter valued at about $2,351,000. Vident Advisory LLC increased its position in shares of Corteva by 4.0% during the fourth quarter. Vident Advisory LLC now owns 21,940 shares of the company's stock worth $1,250,000 after acquiring an additional 837 shares during the period. Finally, Tidal Investments LLC raised its position in Corteva by 18.8% during the 4th quarter. Tidal Investments LLC now owns 123,719 shares of the company's stock valued at $7,047,000 after purchasing an additional 19,587 shares in the last quarter. Institutional investors own 81.54% of the company's stock.
Corteva Stock Performance
Shares of CTVA traded up $1.10 during trading hours on Friday, reaching $70.81. 5,448,040 shares of the company traded hands, compared to its average volume of 3,305,239. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $71.00. The business has a fifty day moving average price of $63.12 and a 200-day moving average price of $61.54. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $48.30 billion, a P/E ratio of 54.89, a P/E/G ratio of 1.68 and a beta of 0.72.
Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.25. The firm had revenue of $4.42 billion during the quarter, compared to analyst estimates of $4.56 billion. Corteva had a net margin of 5.36% and a return on equity of 7.19%. The business's quarterly revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.89 EPS. Equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 2nd will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date of this dividend is Monday, June 2nd. Corteva's dividend payout ratio is currently 41.46%.
Wall Street Analyst Weigh In
A number of research firms have commented on CTVA. Wells Fargo & Company raised their target price on shares of Corteva from $73.00 to $79.00 and gave the company an "overweight" rating in a research report on Monday, May 12th. Morgan Stanley upped their target price on Corteva from $65.00 to $71.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Argus upgraded Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target on the stock in a report on Monday, March 31st. Citigroup upped their price objective on Corteva from $75.00 to $78.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Finally, Bank of America lifted their target price on Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $70.50.
View Our Latest Analysis on CTVA
About Corteva
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.